Panelists discuss how diuretics serve as necessary “bailout therapy” for volume management in heart failure but should not substitute for guideline-directed medical therapy, with emerging evidence ...
Please provide your email address to receive an email when new articles are posted on . High heart failure hospitalization and mortality rates could be due in part to poor medication adherence. A ...
Larry Allen, MD, MHS, and Kenneth B Margulies, MD, discuss HF management for American Heart Month and Heart Failure Awareness Week. Advances in heart failure research and management have led to ...
Panelists discuss how quality metrics should focus on keeping patients out of hospitals through core medical therapies, measuring all-cause hospitalizations and days spent at home in the community, ...
Nutrition is more than just calories, carbohydrates and protein; it can be a powerful tool in managing lung disease and ...
Kidney failure, also known as end-stage renal disease (ESRD), occurs when kidneys lose their ability to filter waste and excess fluids from the blood effectively. This serious condition affects ...
Aaron M Wolfson, MD, and Sarah J Goodlin, MD, discuss nonpharmacologic interventions for patients with heart failure. Despite significant advances in the pharmacologic management of individuals with ...
The promise of remote patient monitoring is showing itself in more and more telemedicine use cases, with huge potential for day-to-day wellness, management of chronic conditions and the promotion of ...
DUBLIN--(BUSINESS WIRE)--Dublin-based FIRE1 today announced that the first Irish patient has been successfully implanted with its FIRE1™ System for remote heart failure monitoring. The innovative ...
Objective: To provide an overview of heart failure with preserved ejection fraction (HFPEF), as well as its pathophysiology, diagnosis, and clinical evidence regarding its pharmacologic management.
New review highlights evolving Pompe disease management, from screening to next-generation therapies and monitoring. Read ...
Pomdoctor Limited ('Pomdoctor' or the 'Company') (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced a strategic upgrade centered on the core track ...